Autologous and allogeneic CAR T-cell therapies: spotlighting the "brain-to-vein" time
Clin Adv Hematol Oncol
.
2022 Mar;20(3):134-137.
Author
Matthew Lunning
1
Affiliation
1
Division of Oncology & Hematology, University of Nebraska Medical Center, Omaha, Nebraska.
PMID:
36607341
No abstract available
Publication types
Interview
MeSH terms
Brain / metabolism
Hematopoietic Stem Cell Transplantation*
Humans
Immunotherapy, Adoptive* / adverse effects
Receptors, Antigen, T-Cell / metabolism
T-Lymphocytes / metabolism
Substances
Receptors, Antigen, T-Cell